"Visit Bon Secours Cancer Institute at Reynolds Crossing in Richmond, Virginia. Bon Secours Cancer Institute at Reynolds Crossing is one of the many Cancer Care & Oncology locations at Bon Secours providing good help to those in need."

During the past decade, Bon Secours Cancer Institute at Reynolds Crossing conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 3 clinical trials were completed, i.e. on average, 9.4% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bon Secours Cancer Institute at Reynolds Crossing" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 10 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored, "NRG Oncology" with 4 trials sponsored and "SWOG Cancer Research Network" with 4 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bon Secours Cancer Institute at Reynolds Crossing" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Bon Secours Cancer Institute at Reynolds Crossing" are "Stage IV Lung Cancer AJCC v8" (5 trials), "Anatomic Stage II Breast Cancer AJCC v8" (4 trials), "Invasive Breast Carcinoma" (4 trials), "Prognostic Stage II Breast Cancer AJCC v8" (4 trials) and "Stage IVA Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Bon Secours Cancer Institute at Reynolds Crossing" in a lesser frequency.

Most popular intervention types in "Bon Secours Cancer Institute at Reynolds Crossing" are "Drug" (23 trials), "Other" (22 trials), "Procedure" (12 trials), "Biological" (9 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Questionnaire Administration" (14 trials), "Biospecimen Collection" (6 trials), "Computed Tomography" (6 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Bon Secours Cancer Institute at Reynolds Crossing" are 21 trials for "All" genders, 6 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Bon Secours Cancer Institute at Reynolds Crossing". undefined are not yet recruiting, 16 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bon Secours Cancer Institute at Reynolds Crossing, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bon Secours Cancer Institute at Reynolds Crossing, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".